Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II StudyJ. Clin. Oncol 2021 May 04;[EPub Ahead of Print], NU Lin, M Pegram, S Sahebjam, N Ibrahim, A Fung, A Cheng, A Nicholas, W Kirschbrown, P Kumthekar
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.